Ltd.;Jiangsu Nhwaluokang Pharmaceutical Research and Development Co.
发明人:
申请号：
EP17878651.3
公开号：
EP3549945A4
申请日:
2017.12.05
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to the field of medicine, and particularly relates to a water-soluble allopregnenolone (3β,5α-tetrahydroprogesterone) derivative, a pharmaceutical composition comprising the same, and use thereof in prevention or treatment of central nervous system diseases, in sedation and hypnosis, in treatment of Alzheimer's disease, in treatment of epilepsy or in treatment of depression, especially postpartum depression.
